切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2023, Vol. 17 ›› Issue (01) : 68 -71. doi: 10.3877/cma.j.issn.1674-0785.2023.01.012

临床研究

间隔支弹簧圈栓塞术对肥厚型梗阻性心肌病的临床疗效及远期随访
李传伟1, 文倩2, 罗浩2,()   
  1. 1. 400042 重庆,陆军特色医学中心(陆军军医大学大坪医院)心血管内科
  • 收稿日期:2021-11-24 出版日期:2023-01-15
  • 通信作者: 罗浩

Long-term clinical efficacy and safety of coil embolization of the septal perforator in patients with hypertrophic obstructive cardiomyopathy

Chuanwei Li1, Qian Wen2, Hao Luo2,()   

  1. 1. Department of Cardiology, the Army medical center (Daping Hospital of the Army Medical University), Chongqing 400042, China; The Chongqing Emergency Medical Center, Chongqing 400042, China
    2. Department of Cardiology, the Army medical center (Daping Hospital of the Army Medical University), Chongqing 400042, China
  • Received:2021-11-24 Published:2023-01-15
  • Corresponding author: Hao Luo
引用本文:

李传伟, 文倩, 罗浩. 间隔支弹簧圈栓塞术对肥厚型梗阻性心肌病的临床疗效及远期随访[J/OL]. 中华临床医师杂志(电子版), 2023, 17(01): 68-71.

Chuanwei Li, Qian Wen, Hao Luo. Long-term clinical efficacy and safety of coil embolization of the septal perforator in patients with hypertrophic obstructive cardiomyopathy[J/OL]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(01): 68-71.

目的

评估经导管弹簧圈栓塞术对肥厚型梗阻性心肌病(HOCM)的临床疗效及长期随访。

方法

回顾性的分析了2017年6月至2018年6月期间于陆军特色医学中心心内科住院并成功行间隔支弹簧圈栓塞的HOCM患者共3例。分析患者的一般情况,术中测压、血管栓塞以及患者长期随访中的症状及超声心动图评估的室间隔厚度及左室流出道与主动脉峰值压力阶差(LVOTG)变化情况。

结果

所有患者术前均表现为不同程度的气促、胸闷等症状。3例患者有创测压LVOTG均大于50 mmHg(1 mmHg=0.133 kPa)。经成功栓塞间隔支后,所有患者即刻造影结果均提示靶血管栓塞效果良好,术中及术后均无明显的高度房室传导阻滞发生。术后即刻效果除病例1欠满意外,病例2中LVOTG由栓塞前的94 mmHg下降至8 mmHg,病例3由99 mmHg降低至32 mmHg。病例1术中LVOTG下降不满意,术后2月猝死。另两例患者术后症状均有所缓解,但随着时间的推移,术后室间隔厚度及LVOTG均有所恢复,但仍低于栓塞前。

结论

HOCM经弹簧圈栓塞间隔支安全、有效,但长期随访有一定程度的恢复。

Objective

To evaluate the safety and long-term clinical efficacy of coil embolization of the septal perforator in patients with hypertrophic obstructive cardiomyopathy (HOCM).

Methods

Data of three HOCM patients who received coil embolization of the septal perforator from June 2017 to June 2018 at Army Medical Center were retrospectively collected. The baseline characteristics, symptoms, left ventricular outflow tract gradient (LVOTG), and maximum interventricular septum thickness before and after the procedure were recorded for analysis.

Results

All the patients complained of varying degrees of dyspnea and chest distress and the LVOTG was higher than 50 mmHg (1 mmHg=0.133 kPa) in all cases. The septal perforator was successfully embolized with coil and demonstrated by target artery angiography without the occurrence of high degree atrioventricular block. The LVOTG was significantly reduced after the procedure except case 1. The LVOTG of case 1 failed to improve and sudden death occurred 2 months after discharge. The symptoms of the other two cases were all relieved but during the long-term follow up, an increase in the LVOTG and maximum interventricular septum thickness was observed.

Conclusion

The results of this pilot study suggest that coil embolization of the septal perforator is feasible and safe but long-term follow-up showed an increase in the LVOTG and maximum interventricular septum thickness to some extent.

表1 肥厚型梗阻性心肌病患者基本情况
表2 肥厚型梗阻性心肌病患者流出道梗阻随访情况
1
Zou Y, Song L, Wang Z, et al. Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults [J]. Am J Med, 2004, 116(1): 14-18.
2
Durand E, Mousseaux E, Coste P, et al. Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up [J]. Eur Heart J, 2008, 29(3): 348-355.
3
中华医学会心血管病学分会中国成人肥厚型梗阻性心肌病诊断与治疗指南编写组. 2017中国成人肥厚型心肌病诊断与治疗指南 [J]. 中华心血管病杂志, 2017, 45(12): 1015-1032
4
Alashi A, Smedira NG, Hodges K, et al. Outcomes in guideline-based class i indication versus earlier referral for surgical myectomy in hypertrophic obstructive cardiomyopathy [J]. J Am Heart Assoc, 2021,10(1): e016210.
5
Ji Q, Wang YL, Yang Y, et al. Mini-invasive surgical instruments in transaortic myectomy for hypertrophic obstructive cardiomyopathy: a single-center experience with 168 cases [J]. J Cardiothorac Surg, 2021,16(1): 25.
6
Bytyçi I, Nistri S, Mörner S, et al. Alcohol septal ablation versus septal myectomy treatment of obstructive hypertrophic cardiomyopathy: a systematic review and meta-analysis [J]. J Clin Med, 2020, 9(10): 3062.
7
Batzner A, Pfeiffer B, Neugebauer A, et al. Survival after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy [J]. J Am Coll Cardiol, 2018, 72(24): 3087-3094.
8
Oto A, Aytemir K, Okutucu S, et al. Cyanoacrylate for septal ablation in hypertrophic cardiomyopathy [J]. J Interv Cardiol, 2011,24(1): 77-84.
9
Guerrero I, Dhoble A, Fasulo M, et al. Safety and efficacy of coil embolization of the septal perforator for septal ablation in patients with hypertrophic obstructive cardiomyopathy [J]. Catheter Cardiovasc Interv, 2016, 88(6): 971-977.
10
Liu F, Fu J, Hsi D, et al. Percutaneous intramyocardial septal radiofrequency ablation for interventricular septal reduction: an ovine model with 1-year outcomes [J]. Cardiology, 2020, 145(1): 53-62.
11
Liu L, Li J, Zuo L, et al. Percutaneous intramyocardial septal radiofrequency ablation for hypertrophic obstructive cardiomyopathy [J]. J Am Coll Cardiol, 2018, 72(16): 1898-1909.
12
Cooper RM, Shahzad A, Hasleton J, et al. Radiofrequency ablation of the interventricular septum to treat outflow tract gradients in hypertrophic obstructive cardiomyopathy: a novel use of CARTOSound® technology to guide ablation [J]. Europace, 2016,18(1): 113-120.
13
Creta A, Elliott P, Earley MJ, et al. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a European observational multicentre study [J]. Europace, 2021, 23(9): 1409-1417.
[1] 吴姗姗, 潘裕民, 刘晋, 张劲松, 乔莉. 睡眠呼吸暂停综合征患者静脉血栓栓塞症发生率的Meta分析[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 312-317.
[2] 姚金含, 王伟娜, 张玉泉. 妊娠相关深静脉血栓形成患者的预后研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 367-373.
[3] 汤宏涛, 何坤. 中晚期肝细胞癌介入治疗的进展及前景[J/OL]. 中华普通外科学文献(电子版), 2024, 18(04): 305-308.
[4] 李国煜, 丛赟, 祖丽胡马尔·麦麦提艾力, 何铁英. 急性胰腺炎并发门静脉系统血栓形成的危险因素及预测模型构建[J/OL]. 中华普通外科学文献(电子版), 2024, 18(04): 266-270.
[5] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[6] 麦子结, 曾学晴, 张乾升, 刘永达. 输尿管软镜术后严重出血治疗的初步探索[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(04): 366-371.
[7] 张春玉, 陈海云, 肖忠萍, 罗琴, 潘运昌. 血清NT-proBNP 预测肺栓塞心脏功能障碍的临床分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 805-808.
[8] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[9] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[10] 刘华亭, 张媛, 张登文, 王杰, 袁阳. 介入栓塞联合手术切除治疗头皮动静脉畸形的疗效观察[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(05): 273-278.
[11] 蔡晓雯, 李慧景, 丘婕, 杨翼帆, 吴素贤, 林玉彤, 何秋娜. 肝癌患者肝动脉化疗栓塞术后疼痛风险预测模型的构建及验证[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 722-728.
[12] 于洁, 金小红, 顾艳楣, 王慧, 葛杨杨, 李燕. 癌症相关静脉血栓栓塞症患者疾病体验与需求的质性研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 739-744.
[13] 崔伟, 邓屹, 叶苏意, 李静, 陈晓明, 张靖, 许荣德. 载药微球支气管动脉化疗栓塞术治疗罕见非小细胞肺癌的临床疗效和安全性分析[J/OL]. 中华介入放射学电子杂志, 2024, 12(04): 303-310.
[14] 崔伟, 叶苏意, 邓屹, 陈晓明, 张靖, 李静, 许荣德. 载药微球支气管动脉化疗栓塞术治疗难治性非小细胞肺癌的临床疗效及安全性[J/OL]. 中华介入放射学电子杂志, 2024, 12(04): 311-316.
[15] 王卫明, 张艺菲, 陈炜, 秦浩, 杨宇光, 王俊, 王琴, 夏莹, 施博文, 董宇超, 白冲, 黄海东. 左主支气管动脉肺静脉瘘致气道狭窄及反复咯血一例[J/OL]. 中华介入放射学电子杂志, 2024, 12(04): 323-326.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?